Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Brooklyn › NPI 1033203070
Physician

Gershkovich, Tibor

Gershkovich, Tibor was paid $509K by Medicaid between Jan 2018 and Nov 2024, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.

33Billing provider infoGERSHKOVICH, TIBOR
BROOKLYN, NY 11214
33aNPI1033203070assigned 10/03/2006
33bProvider typePediatrics Physician
28Total paid$509K
24GClaims19,757
24DCodes billed21
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Pediatrics Physician providers in New York

Rank by total paid#416 of 1,983
Median peer was paid$17K
This provider vs. median30×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,873$66K
20194,385$117K
20202,985$70K
20212,493$62K
20223,008$71K
20232,381$69K
2024incomplete1,632$54K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 45% 3,953 3,152 $227K
90460 Immunization administration through 18 years of age via any route, first or only component 16% 2,985 2,411 $80K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 14% 1,029 704 $69K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4.6% 2,141 1,100 $24K
94644 3.9% 670 446 $20K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3.4% 2,952 2,660 $17K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3.4% 685 636 $17K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2.9% 214 210 $15K
87070 2.2% 1,742 1,575 $11K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.0% 159 134 $10K
87184 1.7% 1,744 1,574 $9K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 189 189 $3K
9 more codes
97803 <1% 409 $3K
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg <1% 553 $3K
99050 <1% 206 $2K
90656 <1% 33 $296.62
92567 <1% 14 $150.13
36410 <1% 35 $108.30
87081 <1% 17 $89.25
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 12 $83.82
90713 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.